Battle Fuel
Natural health product licensed in Canada
- Licence holder
- MusclePharm Corporation
- NPN or DIN-HM
- 80033114
- Status
- Inactive licence
- Licence date
- 26 June 2012
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Linum usitatissimum L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Brassica oleracea L.: L'étiquetage doit comporter un avertissement recommandant aux personnes ayant une hypothyroïdie ou un traitement de la thyroïde de consulter leur médecin.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Urtica dioica L.: L'étiquetage des compléments alimentaires contenant les parties souterraines de cette plante doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Frangula purshiana Cooper: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes ainsi qu'une mention déconseillant l'usage prolongé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Linum usitatissimum Source : Graine(s) | 0.166 mg | Not calculated |
| Eleutherococcus senticosus Source : Racine | 200 mg | Not calculated |
| Trigonella foenum-graecum Source : Graine(s) Extraction ratio : 8:1 Dry plant equivalent : 390 mg | 48.75 mg | Not calculated |
| Taraxacum officinale Source : Racine | 3.75 mg | Not calculated |
| Zingiber officinale Source : Rhizome | 0.166 mg | Not calculated |
| Silybum marianum Source : Graine(s) Potency : 80 % Silymarin | 3.75 mg | Not calculated |
| Brassica oleracea var. capitata Source : En entier | 0.166 mg | Not calculated |
| Urtica dioica Source : Sommité Extraction ratio : 4:1 Dry plant equivalent : 15 mg | 3.75 mg | Not calculated |
| Echinacea angustifolia Source : Rhizome et racine(s) Extraction ratio : 4:1 Dry plant equivalent : 0.664 mg | 0.166 mg | Not calculated |
| Lepidium meyenii Source : Racine Extraction ratio : 4:1 Dry plant equivalent : 84 mg | 21 mg | Not calculated |
| Zinc Source : Monométhionine de Zinc | 0.06 mg | 360 µg |
| Rhodiola rosea Source : Racine Extraction ratio : 10:1 Dry plant equivalent : 150 mg Potency : 3 % Rosavin | 15 mg | Not calculated |
| Panax ginseng Source : Racine | 254 mg | Not calculated |
| Frangula purshiana Source : Écorce âgée | 0.166 mg | Not calculated |
Non-medicinal ingredients
Guimauve, Feuille de persil, Yerba Mate Extract, Extrait de feuilles de menthe poivrée, Microcrystalline cellulose, Gélatine, Stéarate de magnésium, Brassica Oleracea Italica (broccoli) Extract, Poudre d'écorce d'orme rouge, Écorce de Cinnamomum burmannii, Feuille de Rubus idaeus
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 6 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine to help enhance physical capacity/performance. Helps to support cognitive function and/or reduce mental fatigue. Used in Herbal Medicine to help improve mental and/or physical performance after periods of mental and/or physical exertion.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80033114
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.